top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Search

Novartis to Acquire Myricx Bio in Up to $2.9B Deal to Expand ADC Cancer Pipeline

Jul 16
1 min read

Basel, Switzerland, July 6, 2026 (Novartis) -- Novartis has agreed to acquire Myricx Bio in a deal valued at up to $2.9 billion. The acquisition adds Myricx Bio’s next-generation antibody-drug conjugate (ADC) technology, including its novel NMTi payload platform, to strengthen Novartis’ oncology pipeline. The transaction is intended to broaden treatment options for cancer patients and reinforce Novartis’ position in targeted cancer therapies.

Read full article here.

Recent Posts

Bridge Life Sciences Raises $110M to Advance Drug Development Pipeline

Duluth, GA, August 12, 2026 (Yahoo Finance) -- Bridge Life Sciences has raised $110 million in new financing to support the advancement of its therapeutic pipeline. The company plans to use the capi

PacBio Names Mark Van Oene as President and Chief Executive Officer

Menlo Park, CA, August 5, 2026 (PacBio) -- Pacific Biosciences of California has appointed Mark Van Oene as president and chief executive officer, effective August 17, 2026. Van Oene brings extensiv

Tarsus to Acquire Alkeus in Up to $800M Deal to Expand Ophthalmology Pipeline

Irvine, CA, August 6, 2026 (Reuters) -- Tarsus Pharmaceuticals has agreed to acquire Alkeus Pharmaceuticals in a transaction valued at up to $800 million. The deal gives Tarsus access to an investig

Comments

Life Science Headlines

Bridge Life Sciences Raises $110M to Advance Drug Development Pipeline

PacBio Names Mark Van Oene as President and Chief Executive Officer

Tarsus to Acquire Alkeus in Up to $800M Deal to Expand Ophthalmology Pipeline

Versa Vascular Appoints Bill Shields as CEO to Drive Next Phase of Growth

Jazz Pharmaceuticals to Acquire Actio Biosciences in Up to $1.32B Deal for Rare Epilepsy Treatment

Repligen to Acquire BioLife Solutions in $1.5B Deal to Expand Bioprocessing Portfolio

Roche Appoints Dan Malarek as President and CEO of Roche Diagnostics North America

GT Medical Technologies Raises $100M in Oversubscribed Series E Financing to Expand Brain Tumor Treatment

Sarepta Therapeutics Appoints Michael Severino as Chief Executive Officer

Lilly to Acquire Atai Beckley in Up to $1.6B Deal to Expand Mental Health Pipeline

bottom of page